An enzymatic electrochemiluminescence assay for the lethal factor of anthrax.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Analytical Biochemistry

• Publication date

  2003-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0003-2697(03)00424-XPMID 12963063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition

  2002cited by this paper
• Pharmacology: Screening inhibitors of anthrax lethal factor

  2002cited by this paper
• Pharmacology: screening inhibitors of anthrax lethal toxin

  2002cited by this paper
• Quickening the pace of anthrax research: three advances point towards possible therapies.

  2002cited by this paper
• Youth ignorance of HIV/AIDS.

  2002cited by this paper
• Microbiology: Tackling anthrax

  2001cited by this paper
• Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways

  2001cited by this paper
• Identification of the cellular receptor for anthrax toxin

  2001cited by this paper
• Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

  2000cited by this paper
• Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

  1998cited by this paper
• Lethal Factor Active-Site Mutations Affect Catalytic Activity In Vitro

  1998cited by this paper
• Endoproteinase Activity of Type A Botulinum Neurotoxin: Substrate Requirements and Activation by Serum Albumin

  1997cited by this paper
• Proteolysis of synthetic peptides by type A botulinum neurotoxin

  1995cited by this paper
• Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.

  1994cited by this paper
• Zinc content of the Bacillus anthracis lethal factor.

  1994cited by this paper
• Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

  1986influential reference
• Effects of anthrax toxin components on human neutrophils

  1985cited by this paper
• Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

  1982cited by this paper

• Biotin Conjugated Fe(III)-Triscatecholate Complex as Tumour Targeting T1 MRI Contrast Agent via Second Sphere Water Relaxation.

  2024cites this paper
• Validated MALDI-TOF-MS method for anthrax lethal factor provides early diagnosis and evaluation of therapeutics

  2017cites this paper
• An electrochemiluminescence assay for the detection of bio threat agents in selected food matrices and in the screening of Clostridium botulinum outbreak strains associated with type A botulism.

  2014cites this paper
• Biocytin-Based Contrast Agents for Molecular Imaging: An Approach to Developing New In Vivo Neuroanatomical Tracers for MRI

  2012cites this paper
• Distinguishing Tropical Infectious Diseases from Bioterrorism

  2011cites this paper
• Alkaline earth metals are not required for the restoration of the apoform of anthrax lethal factor to its holoenzyme state.

  2010cites this paper
• Ru(bpy)3(2+)-doped silica nanoparticles labeling for a sandwich-type electrochemiluminescence immunosensor.

  2010cites this paper
• Microsphere based protease assays and high throughput screening of bacterial toxin proteases

  2009cites this paper
• Bacillus anthracis: Balancing innocent research with dual-use potential

  2008cites this paper
• Detection and Viability Assessment of Endospore-Forming Pathogens

  2008cites this paper
• Quantitative electrochemiluminescence detection of proteins: Avidin-based sensor and tris(2,2'-bipyridine) ruthenium(II) label.

  2008cites this paper
• A quantitative electrochemiluminescence assay for Clostridium perfringens alpha toxin.

  2006cites this paper
• Synthesis and in vitro evaluation of biotinylated RG108: a high affinity compound for studying binding interactions with human DNA methyltransferases.

  2006cites this paper
• Microsphere‐based protease assays and screening application for lethal factor and factor Xa

  2006cites this paper
• Distinguishing Tropical Infectious Diseases from Bioterrorism

  2006cites this paper
• ANTHRAX LETHAL FACTOR: CRITICAL VIRULENCE FACTOR OF PATHOGENESIS OF ANTHRAX TOXINS

  2006cites this paper
• Rapid and Accurate Detection of Bacillus anthracis Spores Using Peptide-Quantum Dot Conjugates

  2006cites this paper
• Development of high-throughput assay of lethal factor using native substrate.

  2005cites this paper
• Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins

  2004cites this paper
• Anthrax Lethal Toxin Rapidly Activates Caspase-1/ICE and Induces Extracellular Release of Interleukin (IL)-1β and IL-18*

  2004cites this paper
• Bead injection with a simple flow-injection system: an economical alternative for trace analysis

  2004cites this paper
• Ruthenium(II)-phenanthroline-biotin complexes: synthesis and luminescence enhancement upon binding to avidin.

  2004cites this paper